메뉴 건너뛰기
Diabetes Care
Volumn 23, Issue 7, 2000, Pages 1035-1036
Increased plasma plasminogen activator inhibitor 1 in relatives of type 2 diabetic patients
Author keywords

[No Author keywords available]
Indexed keywords

INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;
EID: 0033911306     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.7.1035     Document Type: Note
Times cited : (4)
References (9)
  • 1
    • 0033985274 scopus 로고    scopus 로고
    • Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: Lack of association with plasma insulin levels
    • Gürlek A, Bayraktar M, Kirazli S: Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels. Diabetes Care 23:88-92, 2000
    • (2000) Diabetes Care , vol.23 , pp. 88-92
    • Gürlek, A.1    Bayraktar, M.2    Kirazli, S.3
  • 2
    • 0031051777 scopus 로고    scopus 로고
    • PAI-1 concentrations in first-degree relatives of patients with non-insulin-dependent diabetes: Metabolic and genetic associations
    • Mansfield MW, Stickland MH, Grant PJ: PAI-1 concentrations in first-degree relatives of patients with non-insulin-dependent diabetes: metabolic and genetic associations. Thromb Haemost 77:357-361, 1997
    • (1997) Thromb Haemost , vol.77 , pp. 357-361
    • Mansfield, M.W.1    Stickland, M.H.2    Grant, P.J.3
  • 3
    • 0343805151 scopus 로고
    • Impaired fibrinolysis in offspring of parental pairs with type 2 diabetes mellitus
    • Medvescek M, Keber D, Stegnar M: Impaired fibrinolysis in offspring of parental pairs with type 2 diabetes mellitus (Abstract). Diabetologia 38 (Suppl. 1):A52, 1995
    • (1995) Diabetologia , vol.38 , Issue.SUPPL. 1
    • Medvescek, M.1    Keber, D.2    Stegnar, M.3
  • 4
    • 0025234723 scopus 로고
    • Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease
    • Landin K, Tengborn L, Smith U: Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med 227:273-278, 1990
    • (1990) J Intern Med , vol.227 , pp. 273-278
    • Landin, K.1    Tengborn, L.2    Smith, U.3
  • 5
    • 0027240197 scopus 로고
    • The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance
    • Potter van Loon BJ, Kluft K, Radder JK, Blankenstein MA, Meinders AE: The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance. Metabolism 42:945-949, 1993
    • (1993) Metabolism , vol.42 , pp. 945-949
    • Potter Van Loon, B.J.1    Kluft, K.2    Radder, J.K.3    Blankenstein, M.A.4    Meinders, A.E.5
  • 6
    • 0027303073 scopus 로고
    • Plasminogen activator inhibitor 1 and atherothrombosis
    • Juhan-Vague I, Alessi MC: Plasminogen activator inhibitor 1 and atherothrombosis. Thromb Haemost 70:138-143, 1993
    • (1993) Thromb Haemost , vol.70 , pp. 138-143
    • Juhan-Vague, I.1    Alessi, M.C.2
  • 7
    • 0025251843 scopus 로고
    • Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein
    • Stiko-Rahm A, Wiman B, Hamsten A, Nilsson J: Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein. Arteriosclerosis 10:1067-1073, 1990
    • (1990) Arteriosclerosis , vol.10 , pp. 1067-1073
    • Stiko-Rahm, A.1    Wiman, B.2    Hamsten, A.3    Nilsson, J.4
  • 8
    • 0025882334 scopus 로고
    • Basal expression and insulin-mediated induction of PAI-1 mRNA in Hep G2 cells
    • Grant PJ, Rüegg M, Medcalf RL: Basal expression and insulin-mediated induction of PAI-1 mRNA in Hep G2 cells. Fibrinolysis 5:81-86, 1991
    • (1991) Fibrinolysis , vol.5 , pp. 81-86
    • Grant, P.J.1    Rüegg, M.2    Medcalf, R.L.3
  • 9
    • 0031937736 scopus 로고    scopus 로고
    • Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects
    • Calles-Escandon J, Mirza SA, Sobel BE Schneider DJ: Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects. Diabetes 47:290-293, 1998
    • (1998) Diabetes , vol.47 , pp. 290-293
    • Calles-Escandon, J.1    Mirza, S.A.2    Sobel, B.E.3    Schneider, D.J.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.